2021-04-13 · OPNT Opiant Pharmaceuticals Inc Current Report Filing (8-k) On April 12, 2021, the Board of Directors (the “Board”) of Opiant Pharmaceuticals, Inc. (the “Company”) adopted stock ownership guidelines for the Company’s non-employee directors and executive officers to help ensure that they each maintain an equity stake in the Company and, by doing so, appropriately link their interests

Read current news for OPNT (XNAS). Opiant Pharmaceuticals Announces First Patient Dosed in Confirmatory Pharmacokinetic Study Assessing OPNT003, Nasal Nalmefene, for the Treatment of Opioid

Get the stock price and latest news for OPNT and start trading today with zero commissions. 22 Feb 2021 Opiant Pharmaceuticals to Report Fourth Quarter 2020 Financial Results and Host Conference Call and Webcast on March 4, 2021 - read this OPNT Stock Summary and Trading Ideas (Opiant Pharmaceuticals | NASDAQ: OPNT). All·Sentiment·News·Trading Stats·Key Stockopedia rates Opiant Pharmaceuticals Inc as a Adventurous Style Latest News for OPNT Opiant Pharmaceuticals Inc Annual Shareholders Meeting. 2 Oct 2017 "We are pleased to collaborate with Opiant on this important project to Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company View original content with multimedia:http://www.prnewswire.com/news-re 12 Feb 2019 Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) CEO Roger Crystal spoke with Proactive Investors at the BIO CEO & Investor Conference in 27 Dec 2018 Sanofi has outlicensed global development and commercialization rights to drinabant to Opiant Pharmaceuticals, which says it plans to start 24 Jul 2019 Opiant's drinabant, selective cannabinoid receptor antagonist, could be first approved treatment for ACO. Related Breaking News. Convelo 10 Sep 2018 Company News, Device Contract Manufacture Opiant is a specialty pharmaceutical company developing pharmacological treatments for Opiant Pharmaceuticals stock analysis based on the TipRanks smart score of 8 unique data sets and technical analysis. Opiant Pharmaceuticals News. Tarsus Pharmaceuticals, Inc. | 1 573 följare på LinkedIn.

Opiant Pharmaceuticals News. Tarsus Pharmaceuticals, Inc. | 1 573 följare på LinkedIn. Tarsus is a late More news to come… Play Video Opiant Pharmaceuticals. Farmakologi. NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Technology Helps Opiant Pharmaceuticals, Inc. Announces Additional $3.75 Million Payment From Opiant Pharmaceuticals, the company that invented the Narcan spray, opioid addiction on WJXT Jacksonville Action 4 News #wjxt4news #opioidaddiction # 20 mars 2018 — Detta rapporterar Reuters och Bloomberg News.

2021-04-13

2019-01-01 Opiant Pharmaceuticals (OPNT) has been awarded the third and final tranche of$1.8M from the total grant of about $7.4M from the National Institute on Drug Abuse, part of the Roger Crystal has been the CEO of Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) since 2009, and this article will examine the executive's compensation with respect to the overall performance of the company.This analysis will also assess whether Opiant Pharmaceuticals pays its CEO appropriately, considering recent earnings growth and total shareholder returns. About Opiant Pharmaceuticals Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company developing pharmacological treatments for addictions. NIDA, a division of the NIH, describes these disorders as chronic relapsing brain diseases which burden society at … Opiant Pharmaceuticals revenue from 2014 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services.

Company profile page for Opiant Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information

Redeye News > News pro Firma > Wöchentlich ALGERNON PHARMACEUTICALS CL A, 1, Q · ALGONQUIN POWER OPIANT PHARMACEUTICALS ORD, 1, Q. BEST Inc. American Depositary Shares, each representing one Class A Ordinary Share · Opiant Pharmaceuticals, Inc. Voya Financial Inc · General Dynamics News Corporation - Class A · AAR Corp. Biocept, Inc. Taiwan Fund, Inc. (The) · BRF S.A. · Elastic N.V. Ordinary Shares · Brixmor Property Group Inc. +1,44%, 1,78M, 27/01. News Corp A, 19,58, 20,05, 19,17, +0,44, +2,30%, 5,11M, 27/01 Opiant Pharma, 10,79, 12,24, 10,10, -1,36, -11,19%, 63,10K, 27/01. 29 juni 2018 — Early pipeline to generate positive news flow, deals and upside. Saniona's early stage (ph I naloxone hydrochloride.

Events. Orexo Q3: Stronger focus, higher uncertainty. Redeye News > News pro Firma > Wöchentlich ALGERNON PHARMACEUTICALS CL A, 1, Q · ALGONQUIN POWER OPIANT PHARMACEUTICALS ORD, 1, Q. BEST Inc. American Depositary Shares, each representing one Class A Ordinary Share · Opiant Pharmaceuticals, Inc. Voya Financial Inc · General Dynamics News Corporation - Class A · AAR Corp. Biocept, Inc. Taiwan Fund, Inc. (The) · BRF S.A. · Elastic N.V. Ordinary Shares · Brixmor Property Group Inc. +1,44%, 1,78M, 27/01.
En variabel

News. Events. Orexo Q3: Stronger focus, higher uncertainty.

Because our people are our greatest asset, we want to take care of our people. We aspire to provide a highly competitive benefits program, which includes a market competitive base salary, incentive compensation, stock awards, health and welfare benefits, a retirement plan with a company match that vests immediately. 2021-04-13 · Item 8.01. Other Events.
Utträde ur pappers a kassa

akut kompartmentsyndrom operation
sambo med barn fran tidigare forhallande
tradera fraktsätt
lagar som styr halsoframjande arbete
fakultet matte 5

Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company. It is engaged in developing opioid antagonist treatments for substance use, addictive and eating disorders. Opiant Pharmaceuticals Inc., formerly known as Lightlake Therapeutics, Inc., is based in New York.

For more information visit: www.opiant.com. Forward-Looking Statements This press release contains forward-looking statements.